Anna Dopler

In June 2020, I joined the NKI as a PhD student. In my projects, I investigate the role of ribosomal heterogeneity in tumor cells and how this impacts their sensitivity to T cell response. By combining both cancer immunology and fundamental ribosome research, the goal of my projects is to provide novel insights into important aspects driving the T cell based immunosurveillance of tumors.